How ORILISSA works

A next step for moderate to severe endometriosis pain



The first FDA-approved oral treatment for moderate to severe endometriosis pain in over a decade1


GnRH antagonist
mechanism of action1

Learn about the GnRH
antagonism mechanism of
action (MOA).

Pharmacology

Learn about the pharmacologic properties of ORILISSA.



ORILISSA dosing1

Dosing information for the two
available oral formulations.

150 mg QD   200 mg BID

Clinical snapshots

Peer dosing case studies and a customizable patient profile.

Back to top